Aggressive Plattenepithelkarzinome auf dem Boden eines Lichen ruber mucosae: Bericht über drei Fälle
Neda Cramer, Dagmar Wilsmann‐Theis, Michael P. Schön, Joerg Wenzel et autres
0 citationsJDDG Journal der Deutschen Dermatologischen Gesellschaft
Joerg Wenzel
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
335Publications signalées
12035Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Systemic Lupus Erythematosus ResearchT-cell and B-cell ImmunologyAutoimmune Bullous Skin DiseasesDermatology and Skin DiseasesCutaneous lymphoproliferative disorders research
Publications récentes
Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions
Ksenia Kalyniuk, Tanja Fetter, Marie Grützbach, Tugce Guel et autres
3 citationsFrontiers in Immunology
Beneath the surface: delineating the subtypes of Dowling–Degos disease
Sheetal Kumar, Damian J. Ralser, Joerg Wenzel, Jorge Frank et autres
4 citationsBritish Journal of Dermatology
18F-FDG-PET and Multimodal Biomarker Integration: A Powerful Tool for Alzheimer’s Disease Diagnosis
Yvonne Bouter, Robert M. Glasnek, Joerg Wenzel, Caroline Bouter
9 citationsNuclear Medicine and Molecular Imaging
Erfolgreiche Behandlung eines subakut kutanen Lupus erythematodes mit dem TYK‐2‐Inhibitor Deucravacitinib bei einer Patientin mit begleitender Psoriasis vulgaris
Katharina Assaf, Selina Patt, Valentin Sebastian Schäfer, Joerg Wenzel et autres
0 citationsJDDG Journal der Deutschen Dermatologischen Gesellschaft
Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study
T Witte, Ruth Fernandez‐Ruiz, Nadezda Abramova, Dominika Weinelt et autres
15 citationsLupus Science & Medicine
Rethinking deep learning in bioimaging through a data centric lens
Jiajun Cao, Joerg Wenzel, Shanghang Zhang, Josephine Lampe et autres
10 citationsnpj Imaging
LB0004 RANDOMISED, PLACEBO-CONTROLLED PHASE II STUDY OF ORAL ENPATORAN, A FIRST-IN-CLASS TOLL-LIKE RECEPTOR 7/8 INHIBITOR, IN SYSTEMIC LUPUS ERYTHEMATOSUS
Eric F. Morand, Maria Dall’Era, Jorge Sánchez‐Guerrero, Dess Pearson et autres
4 citationsAnnals of the Rheumatic Diseases
RANDOMIZED, PLACEBO-CONTROLLED PHASE II STUDY OF ENPATORAN, A SMALL MOLECULE TOLL-LIKE RECEPTOR 7/8 INHIBITOR, IN CUTANEOUS LUPUS ERYTHEMATOSUS: RESULTS FROM COHORT A
David R. Pearson, Eric F. Morand, Joerg Wenzel, Richard Furie et autres
13 citationsThe Journal of Rheumatology
The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysis
Susan Manzi, Jorge Sánchez‐Guerrero, Naoto Yokogawa, Joerg Wenzel et autres
7 citationsLupus
Successful Treatment of Erythroderma in a Psoriasis Patient, Developed After Anti‐IL‐17, Anti‐IL‐23 and Anti‐IL‐4/IL‐13 Treatment, With Deucravacitinib
Tugce Guel, Luka de Vos‐Hillebrand, Dagmar Wilsmann‐Theis, Natalija Novak et autres
0 citationsJEADV Clinical Practice
Successful treatment of subacute cutaneous lupus erythematosus with the TYK‐2 inhibitor deucravacitinib in a patient with concomitant psoriasis vulgaris
Katharina Assaf, Selina Patt, Valentin Sebastian Schäfer, Joerg Wenzel et autres
2 citationsJDDG Journal der Deutschen Dermatologischen Gesellschaft
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.